What if you could use medical LSD to treat schizophrenia and other disorders? Well, new research may have found a way.

Sandoz has signed a global collaboration agreement with Shanghai Henlius Biotech to commercialize a biosimilar of oncology therapy, ipilimumab (Bristol-Myers Squibb’s Yervoy). The agreement is ...

LONDON, April 28 (Reuters) - The chief executive of generic drugmaker Sandoz (SDZ.S), opens new tab said a proposal by the CEOs of Novartis (NOVN.S), opens new tab and Sanofi (SASY.PA), opens new ...

Sandoz alleges that Amgen blocked competition ... of reference medicines Prolia and Xgeva. They have the same dosage form, route of administration, dosing regimen, and presentation as the ...

ZURICH, April 14 (Reuters) - Swiss generic drug manufacturer Sandoz (SDZ.S), opens new tab said on Monday it had filed an antitrust lawsuit in the United States against Amgen (AMGN.O), opens new ...

Sandoz has filed an antitrust lawsuit in the United States against Amgen, for extending and entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept). The drug was ...

Agreement will secure a reliable supply of affordable, quality sterile injectables made in Canada With this decision, Sandoz solidifies its position as the #1 supplier of sterile injectables to ...

Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturer Agreement will secure a reliable supply of affordable, quality sterile injectables ...

Sandoz is one of the largest off-patent pharmaceutical manufacturers in the world. It generates roughly 75% of sales from generic drugs with the remainder from biosimilars and has a significant ...

Sandoz expects the settlement, which is subject to approval from a Pennsylvania federal court, to be finalized before the end of the year. Those involved in the settlement have the right to opt ...

In 1938, chemist Albert Hofmann was working at the Swiss pharmaceutical company Sandoz, where he first synthesised lysergic acid diethylamide or LSD. But it wasn't until five years later ...

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...